Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
Public ClinicalTrials.gov record NCT01685567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to obtain and establish the safety and efficacy of The MICHI™ Neuroprotection System with Filter (MICHI™ NPS+f) for providing cerebral embolic protection during angioplasty and stenting procedures in carotid arteries. The MICHI NPS+f also facilitates access to the carotid and neuro anatomy for the introduction of therapeutic or diagnostic endovascular devices and/or agents. It will be used in conjunction with a FDA approved carotid artery stent for the treatment of carotid artery disease.
Study identification
- NCT ID
- NCT01685567
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 219 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2012
- Primary completion
- Feb 29, 2016
- Completion
- Jun 30, 2016
- Last update posted
- Jul 6, 2017
2012 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Peter Morton UCLA Medical Center | Los Angeles | California | 90095 | — |
| Florida Hospital | Orlando | Florida | 32804 | — |
| Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| University of Michigan Medical Center | Ann Arbor | Michigan | 48109-5967 | — |
| McLaren Regional Medical Center | Flint | Michigan | 48507 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Albany Medical Center | Albany | New York | 12208 | — |
| University at Buffalo Neurosurgery, Inc | Buffalo | New York | 14203 | — |
| Columbia University | New York | New York | 10032 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44106 | — |
| University Hospitals Case Medical Center and Case Western Reserve University School of Medicine | Cleveland | Ohio | 44106 | — |
| Riverside Methodist Hospital | Columbus | Ohio | 43214 | — |
| Jobst Vascular Institute | Toledo | Ohio | 43606 | — |
| Oklahoma Heart | Oklahoma City | Oklahoma | 73120 | — |
| Greenville Hospital System | Greenville | South Carolina | 29615 | — |
| Cardiothoracic & Vascular Surgeons | Austin | Texas | 78756 | — |
| Methodist Medical Center | Dallas | Texas | 75208 | — |
| Dallas VA Medical Center | Dallas | Texas | 75216 | — |
| Sentara Vascular Specialists | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01685567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 6, 2017 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01685567 live on ClinicalTrials.gov.